Alliance for Pandemic Preparedness

April 8, 2021

COVID-19 Vaccine Hesitancy among Individuals with Cancer Autoimmune Diseases and Other Serious Comorbid Conditions

Category:

Topic:

Keywords (Tags):

  • [Pre-print, not peer-reviewed] Nearly 1 in 5 individuals with serious comorbid conditions expressed COVID-19 vaccine hesitancy in an international cross-sectional survey conducted from January to February 2021. Participants (n=22,000, 74% from the US) were randomly sampled from Inspire, a large online health community of individuals with comorbid conditions. 10% of participants declared they would not get vaccinated, 4% stated they probably would not, and 5% were not sure they would agree to vaccination (total hesitancy 19%). Factors associated with hesitancy included younger age, female gender, belonging to an ethnic minority group, and distrust of media coverage. 25% of participants reported receiving at least one dose of a COVID-19 vaccine, 29% of whom were US participants.

Tsai et al. (Apr 7, 2021). COVID-19 Vaccine Hesitancy among Individuals with Cancer Autoimmune Diseases and Other Serious Comorbid Conditions. Pre-print downloaded Apr 8 from https://doi.org/10.1101/2021.04.06.21254014